Evidence map›Paper›PMID 42294545›Full record

ArticleAsia-Pacific journal of public health2026

Deafblindness in Aotearoa, New Zealand: Prevalence and Equity Challenges From a Cross-Sectional Census Analysis.

Sally Britnell, Nick Garrett, Claire Bretherton

Abstract read
In one paragraph

Article in Asia-Pacific journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sally BritnellSchool of Nursing, Faculty of Health and Environmental Sciences, Auckland University of Technology, New Zealand.
Nick GarrettSchool of Interprofessional Health Studies, Faculty of Health and Environmental Sciences, Auckland University of Technology, New Zealand.
Claire BrethertonData and Insights, Whaikaha - Ministry of Disabled People, Wellington, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deafblindness or difficulty seeing and hearing even with correction or hearing aids affects an estimated 7.4% (about 295 000) of New Zealanders, with prevalence rising sharply among older adults. Analysis of 2023 Census data using the Washington Group Short Set (WGSS) highlights not only the scale of this issue but also its inequitable distribution: gender-diverse people, Māori, Pacific peoples, and rural communities experience higher rates and earlier onset of sensory difficulties. However, the WGSS's Western, individualistic framing often undercounts deafblindness in Indigenous and collectivist cultures, risking invisibility for those most affected. Geographic disparities further compound inequity, with rural regions facing greater barriers to care. These findings reveal that current measurement tools and policies may not fully capture the lived realities of deafblind people, limiting access to services and perpetuating disadvantage. Addressing these gaps requires culturally responsive data collection, co-design with affected communities, and integrated, holistic support systems. Recognising deafblindness as a distinct disability and aligning policy with Te Tiriti o Waitangi and the United Nations Convention on the Rights of Persons with Disabilities are essential steps towards equity and inclusion.

Indexed as

Deaf-Blind DisordersHealth Status DisparitiesAdultAgedCensusesCross-Sectional StudiesFemaleHumansMaleMaori PeopleMiddle AgedNew ZealandPacific Island PeoplePrevalenceRural PopulationSexual and Gender Minoritiesdeafblindnessdual sensory impairmentNew Zealandprevalencepublic health

Identifiers

PMID42294545
PMCPMC13401624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.